Skip to content
JALM Talk Podcast cover art

All episodes

JALM Talk Podcast, 176 episodes. Page 1 of 2.

#
Title
1

Sixth Generation High-Sensitivity Cardiac Troponin T: Will a Better Assay Make a Better Biomarker?

2

Benchmarking Institutional Support for Point-of-Care Testing Programs: Scale, Staffing, and Operational Challenges

3

Potassium Reference Intervals: A Need for Separate Reference Intervals for Serum and Plasma

4

Current State and Needs of Clinical Laboratories in Latin America: A Cross-Country Assessment

5

Current Challenges and Needs of Clinical Laboratories in the Asia–Pacific Region: A Cross-Country Assessment

6

Tacrolimus Assay Comparison: Analytical and Operational Considerations for Immunoassay vs Mass Spectrometry Testing in a High Volume Clinical Laboratory

7

Immunotyping as an Alternative to Reducing Agents for Resolving Monoclonal Immunoglobulin Aggregates Observed on Immunofixation

8

Assessment of Instrument-Specific Variation between Measured and Calculated Bicarbonate

9

Ordering Practices and Utilization of a Next-Generation Sequencing Panel for Myeloproliferative Neoplasms

10

An Overview of Allowable Total Error in the Clinical Laboratory

11

Toward Sustainable Clinical Chemistry: Waste Quantification and Reduction Strategies from Testing on 4 Commonly Used Automated Analyzers

12

Design and Analytical Evaluation of an Immunoassay for Long Forms of Cardiac Troponin T

13

Assessing and Resolving Findings of Sex Chromosome Discordance in Genetic Testing

14

ADLM Guidance Document on Laboratory Testing for Drugs of Misuse to Support the Emergency Department

15

Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies

16

Blood Utilization and Waste Following Implementation of Thromboelastography

17

ADLM Guidance Document on Coagulation Testing in Patients Using Direct Oral Anticoagulants

18

Handling Hemolytic Blood Samples from High-Risk Clinical Areas: A Call to Action

19

SBC-SHAP: Increasing the Accessibility and Interpretability of Machine Learning Algorithms for Sepsis Prediction

20

MedPromptExtract (Medical Data Extraction Tool): Anonymization and High-Fidelity Automated Data Extraction Using Natural Language Processing and Prompt Engineering

21

Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System

22

The 2024 PhD Board-Certified Clinical Chemist Compensation Survey

23

Fetal Fraction Methodologies and Their Clinical Use: Results of a College of American Pathologists Exercise

24

Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome

25

Price Variability of Eight Common Laboratory Tests across All Licensed Tennessee Hospitals

26

Comparison of 2 Sets of Immunoassays Used in Modified 2-Tiered Testing Algorithms for the Diagnosis of Lyme Disease

27

High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness

28

Total Prostate-Specific Antigen (PSA) Testing in Capillary Samples: Proof-of-Principle and Feasibility Study for Home Self-Testing for Prostate Cancer

29

Clinician-Ordered Peripheral Smear Review by a Pathologist Has Low Clinical Utility—A Reference Laboratory Perspective

30

Developing Benchmarking Metrics for Appropriate Ordering of Vitamin D, Thyroid Testing, and Iron Workups

31

Survey of Laboratory Stewardship Governance at US Academic Medical Centers

32

One Size Fits Small: The Narrow Utility for Plasma Metagenomics

33

An Introduction to the Complete Blood Count for Clinical Chemists: Platelets

34

Cardiac Troponin to Adjudicate Subclinical Heart Failure in Diabetic Patients and a Murine Model of Metabolic Syndrome

35

Recent Recall of Iron Reagent—Investigation of Potential Reagent Contamination and Assay Improvement Strategy

36

Glycated Albumin to Predict Adverse Neonatal Outcomes among Women with Diabetes and Overweight or Obese Body Mass Index

37

ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins

38

Performance of fentanyl immunoassays in an ED patient population

39

Breaking the Chain: Navigating the Pitfalls of Total Laboratory Automation

40

Utility of Cystatin C-based Equation for the Estimation of Glomerular Filtration Rate in a Pediatric Population

41

Implementation of a Self-Audit Tool Improves Regulatory Compliance for Point-of-Care Respiratory Virus Testing in the Emergency Department

42

ADLM Guidance Document on Laboratory Diagnosis of Respiratory Viruses

43

Not Carfentanil—A Case of Unexpected Xylazine Detection

44

A Mathematical Algorithm for Dried Blood Spot Quality Assessment and Results concerning Quality from a Newborn Screening Program

45

Development of a Rapid Qualitative Screen for Anticoagulant Presence

46

Immunoassay Testing of Alpha-Gal Specific Immunoglobulin-E: Data from a National Reference Laboratory

47

The Role of Artificial Intelligence for Providing Scientific Content for Laboratory Medicine

48

Elucidating the Clinical Interpretation and Impact of a Positive Plasma Cell-Free DNA Metagenomics Test Result—A Single Center Retrospective Study

49

Point: The Need for Additional FDA Regulations in Laboratory Medicine; Counterpoint: Why the FDA Should Not Regulate Laboratory-Developed Tests

50

Clinical Utility and Long-Term Feasibility of Exome and Genome Reanalysis: From the Perspectives of a Clinical Laboratory

51

When Positive is Negative: Health Literacy Barriers to Patient Access to Clinical Laboratory Test Results

52

Robust Response of the Clinical Laboratory to the COVID-19 Pandemic despite Significant Challenges

53

Analytical Performance Evaluation of Three Point-of-Care CBC Analyzers for Management of Clozapine Therapy in Ambulatory Psychiatry Clinics

54

Cardiac Troponin T Degradation in End-Stage Renal Disease Patients Appears to Occur in Vivo

55

Global Heatwaves Threaten Integrity of Patient Test Results: A Dire Warning for the Lab Medicine Community

56

Raising the Dead Volume: Analysis of Microsamples Diluted and Corrected with Near Infrared Tracer

57

AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care

58

Inverse Associations between Measures of Adiposity and Glycated Albumin in US Adults, NHANES 1999–2004

59

Pediatric Reference Value Profiling of Essential Trace and Toxic Elements in Healthy Children and Adolescents Using High-Resolution and Triple Quadrupole Inductively Coupled Plasma Mass Spectrometry

60

Clinical Laboratory Approaches for Diagnoses of Sleep-Disordered Breathing and ADHD-Like Behavior in Children

61

AACC Guidance Document on the Clinical Use of Procalcitonin

62

Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit

63

Comparison of a Novel Thin-Walled 25-gauge Needle Push Button Blood Collection Set to a Standard 23-gauge Needle in a Cancer Patient Population

64

AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis

65

Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing?

66

On Developing Better Practices for Reproducible Data Analysis in Laboratory Medicine

67

End to End Data Automation for Pooled Sample SARS-CoV-2 Using R and Other Open-Source Tools

68

Risk Analysis for Quality Control Part 2: Theoretical Foundations for Risk Analysis

69

CRP and High-Sensitivity CRP: "What's in a Name?"

70

Overprediction of Carbapenemase-Containing Isolates by an Automated AST Instrument's Computer Algorithm

71

It's VALID, but Is It Rational?

72

Decreasing the Lower Limit of Quantitation for Urine Albumin Improves Clinical Utility

73

The Biological Variability of Plasma Ceramides in Healthy Subjects

74

Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy

75

AACC Guidance Document on the Use of Point-of-Care Testing in Fertility and Reproduction

76

Point-of-Care: Roadmap for Analytical Characterization and Validation of a High Sensitivity Cardiac Troponin I Assay in Plasma and Whole Blood Matrices

77

Contemporary Challenges in Clinical Flow Cytometry: Small Samples, Big Data, Little Time

78

Predicting Direct-Specimen SARS-CoV-2 Assay Performance Using Residual Patient Samples

79

Utilizing Longitudinal Within-Individual Changes of Serum Creatinine, Cystatin C, and/or eGFR to Optimize Clinical Sensitivity and Eliminate Race and Gender Corrections

80

Impact of the AACC Global Laboratory Quality Initiative in Partnership with Professional Societies and Universities in Latin America and the Caribbean

81

Engaging Laboratory Staff in Stewardship: Barriers Experienced by Medical Laboratory Technologists in Canada

82

Development and Implementation of One-Step, Broad-Spectrum, High-Sensitivity Drug Screening by Tandem Mass Spectrometry in a Pediatric Population

83

Evaluation of Three Anti-SARS-CoV2 Serologic Immunoassays for Post-vaccine Response

84

Correlation of ANA Characteristics with pANCA IFA Interference

85

Anti-Nuclear Antibody Quantitation: Calibration and Harmonization Adjustment via Population Interrogation

86

The 2021 PhD Board-Certified Clinical Chemist Compensation Survey

87

AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury

88

More than Just Contaminants: Frequency and Characterization of Polymicrobial Blood Cultures from a Central Clinical Microbiology Laboratory Serving a Large Healthcare System

89

Validation of a Commercial Reagent for the Depletion of Biotin from Serum/Plasma: A Rapid and Simple Tool to Detect Biotin Interference with Immunoassay Testing

90

Use of a Daratumumab-Specific Immunofixation Assay to Assess Possible Immunotherapy Interference at a Major Cancer Center: Our Experience and Recommendations

91

A Multicenter Evaluation of a Point-of-Care Blood Glucose Meter System in Critically Ill Patients

92

Rapid Quantification of Plasma Creatinine Using a Novel Kinetic Enzymatic Assay

93

AACC Guidance Document on Laboratory Testing for the Assessment of Preterm Delivery

94

How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned.

95

Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury – A Pilot Study

96

Engaging Pathology Residents in Clinical Chemistry: The Essential Ingredient Is a Committed Teacher

97

Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies

98

A Shared Diagnostic Stewardship Approach toward Improving Autoimmune Encephalopathy Send-out Testing Utilization

99

On the Basis of Race: The Utility of a Race Factor in Estimating Glomerular Filtration

100

The Medical Students' Perspective of Health Disparities and a Raced Based Curriculum: Addressing Disparities in Medical Education